HORSHAM, Pa., April 27, 2017 -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company dedicated to developing and commercializing innovative products for the treatment of serious dermatological disorders, and best-in-class products for the medical aesthetic market, will release first quarter financial results on Thursday, May 11, after the market close. STRATA Skin Sciences President and Chief Executive Officer, Frank J. McCaney, and Christina Allgeier, Chief Financial Officer, will host a conference call at 4:30 pm Eastern Time to review the Company’s progress and answer questions.
| Conference Call Details: | |
| Date: | Thursday, May 11 |
| Time: | 4:30 pm Eastern Time |
| Toll Free: | 888-857-6930 |
| International: | 719-325-2432 |
| Passcode: | 3263032 |
| Webcast: | www.strataskinsciences.com |
| Replays, available through May 25, 2017 | |
| Toll Free: | 844-512-2921 |
| International: | 412-317-6671 |
| Replay PIN: | 3263032 |
About STRATA Skin Sciences, Inc. (www.strataskinsciences.com)
STRATA Skin Sciences is a medical technology company focused on the therapeutic and medical-aesthetic dermatology market. STRATA sales include the following products: the XTRAC® laser and VTRAC® excimer lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions; the STRATAPEN™ MicroSystems, a micropigmentation device which provides advanced technology and exceptional results; and Nordlys, a multi-technology aesthetic laser device for treating vascular and pigmented lesions.
Investor Contacts: Christina L. Allgeier STRATA Skin Sciences, Inc. 215 619 3267 [email protected] Bob Yedid LifeSci Advisors, LLC 646-597-6989 [email protected]


WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth
OpenAI Faces Revenue Pressure and User Growth Challenges Ahead of IPO
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Spirit Airlines Gains Key Creditor Support for $500M Bailout Deal
Microsoft Azure Growth Forecast Beats Expectations Amid Rising AI Competition
Google Secures Pentagon AI Deal for Classified Projects
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S.
Samsung Reports Record Profit as AI Boom Drives Memory Chip Demand
TSMC Exits Arm Holdings with $231 Million Share Sale Amid Strategic Portfolio Shift
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth
Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector
Australia Targets Meta, Google, and TikTok With New News Payment Tax Proposal 



